This course has expired. You can still review the content but course credit is no longer available.
Supported by an educational grant from Allergan and EyePoint Pharmaceuticals.
Upon completion of this activity, the participant should be able to:
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To obtain AMA PRA Category 1 Credit™ for this activity, you must read the activity in its entirety and complete the Pretest/Posttest/Activity Evaluation/Satisfaction Measures Form, which consists of a series of multiple-choice questions.
The following faculty/staff members have the following financial relationships with commercial interests:
Thomas A. Albini, MD
Dr. Albini has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Speaker’s Bureau/Grant/Research/Support: Alimera, Allergan, Bausch + Lomb, Eyepoint, Genentech, and Regenexbio. Alimera, Allergan, Bausch + Lomb, Eyepoint, Genentech, Regenexbio; Investigator in MUST and MACTEL study.
Nathan M. Radcliffe, MD
Dr. Radcliffe has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Alcon, Alimera, Allergan, Bausch & Lomb, Ellex, Endo Optiks, Equinox Glaukos Reichert, Iridex, Lumenis, New World Medical, Novartis, and Sight Sciences. Speaker’s Bureau: Aerie, Alcon, Alimera Allergan, Bausch & Lomb, Carl Zeiss Meditec, CATS Ellex, Endo Optiks, Equinox, Eyenovia, Eyepoint, Glaukos, Iridex, Ivantis, Lumenis, New World Medical, Novartis Ocular Science Omeros, Reichert, Sight Sciences, Shire, Thea, Pharmaceuticals
Editorial Support Disclosures
Erin K. Fletcher, MIT, director of compliance and education; Susan Gallagher-Pecha, director of client services and project management; Cassandra Richards, director of education development, Evolve; and Michelle Dalton, writer, have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Allergan, or EyePoint Pharmaceuticals.